Novo Nordisk has partnered with ORA, a leading telehealth provider, to transform the way obesity is addressed in the Philippines. The collaboration merges Novo Nordisk’s clinical expertise with ORA’s fully digital care platform to provide end-to-end obesity care—from virtual consultations to personalized treatment plans and convenient medication delivery.
A New Era of Accessible Obesity Care
For many Filipinos, seeking treatment for obesity is often hindered by stigma, cost, and limited access to doctors. This partnership aims to remove these barriers by enabling patients to receive care from the comfort and privacy of their own homes.
Through ORA’s digital platform, patients can access:
- Virtual consultations with licensed healthcare professionals
- Personalized weight management plans tailored to individual needs
- Medication delivery straight to their doorstep
Part of the Truth About Weight Campaign
This initiative is aligned with Novo Nordisk’s Truth About Weight (TAW) campaign in the Philippines, which focuses on:
- Raising awareness about obesity as a chronic disease
- Dispelling harmful myths and stigma
- Encouraging science-based treatment approaches
By combining advanced medical expertise with telehealth technology, Novo Nordisk and ORA hope to empower Filipinos to take proactive steps toward better health.
A Partnership for Healthier Lives
The official signing was attended by key leaders from both organizations, including:
- Thalia Bondoc, Director for Marketing, ORA
- Tom Reynolds, Vice President for Marketing, ORA
- Wei Sun, General Manager, Novo Nordisk Philippines
- Geraldine Perez, Market Access & Business Development Director, Novo Nordisk Philippines
Also present were dedicated team members from both Novo Nordisk Philippines and ORA who helped bring this initiative to life.
With this partnership, obesity care in the Philippines is taking a big step forward—making treatment more accessible, affordable, and stigma-free for every Filipino who needs it.
0
20
20